e-learning
resources
Munich 2006
Monday 04.09.2006
Cystic fibrosis lung disease: infection, inflammation or both?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The relevance of epidemic ET-12
B. cenocepacia
lipopolysaccharide (LPS) structure and cytokine induction capacity compared to other
burkholderia cepacia
complex species
A. De Soyza, C. Aldridge, A. Silipo, C. M. A. Khan, A. Molinaro, P. A. Corris (Newcastle upon Tyne, United Kingdom; Naples, Italy)
Source:
Annual Congress 2006 - Cystic fibrosis lung disease: infection, inflammation or both?
Session:
Cystic fibrosis lung disease: infection, inflammation or both?
Session type:
Thematic Poster Session
Number:
2798
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. De Soyza, C. Aldridge, A. Silipo, C. M. A. Khan, A. Molinaro, P. A. Corris (Newcastle upon Tyne, United Kingdom; Naples, Italy). The relevance of epidemic ET-12
B. cenocepacia
lipopolysaccharide (LPS) structure and cytokine induction capacity compared to other
burkholderia cepacia
complex species. Eur Respir J 2006; 28: Suppl. 50, 2798
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
TNF and LTA gene polymorphisms in cystic fibrosis patients with Burkholderia cepacia complex (Bcc)
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021
The role of MBL in
B. cepacia
infections in CF patients
Source: Eur Respir J 2005; 26: Suppl. 49, 403s
Year: 2005
Phenotypic assessment of potential
Burkholderia cepacia
virulence associated determinants
Source: Eur Respir J 2003; 22: Suppl. 45, 503s
Year: 2003
Antimicrobial activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and in biofilm
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017
Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients
Source: Eur Respir J 2004; 23: 851-856
Year: 2004
Biofilm production and adherence to airway epithelial cells of
P. aeruginosa
strains: effect of N-acetyl-cysteine
Source: Eur Respir J 2005; 26: Suppl. 49, 726s
Year: 2005
Burkholderia cepacia
complex infection in Czech patients with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 503s
Year: 2003
IL-6 and IL-8 production induced by Pseudomonas aeruginosa flagellin in human bronchial epithelial cells.
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in vivo
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
Human airway epithelial cell response to
Pseudomonas aeruginosa
virulence factors preceded or not by
Staphylococcus aureus
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006
Changes in local and systemic inflammatory markers in cystic fibrosis patients chronically infected with Burkholderia cepacia complex
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020
Proteomics based investigations of
burkholderia cepacia
complex species
Source: Eur Respir J 2006; 28: Suppl. 50, 327s
Year: 2006
Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model
Source: Eur Respir J 2007; 29: 965-968
Year: 2007
Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response
Source: Eur Respir J 2007; 30: 1167-1172
Year: 2007
Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis.
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro
Source: Eur Respir J 2003; 21: 401-406
Year: 2003
Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa
Source: Eur Respir J 2011; 38: 409-414
Year: 2011
The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
Broad spectrum of virulence of
pseudomonas aeruginosa
clones characterized in a murine airway infection model
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept